Federation Des Caisses Desjardins Du Quebec Charles River Laboratories International, Inc. Transaction History
Federation Des Caisses Desjardins Du Quebec
- $19 Billion
- Q1 2025
A detailed history of Federation Des Caisses Desjardins Du Quebec transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Federation Des Caisses Desjardins Du Quebec holds 151 shares of CRL stock, worth $20,936. This represents 0.0% of its overall portfolio holdings.
Number of Shares
151
Previous 739
79.57%
Holding current value
$20,936
Previous $136,000
83.82%
% of portfolio
0.0%
Previous 0.0%
Shares
28 transactions
Others Institutions Holding CRL
# of Institutions
650Shares Held
55MCall Options Held
695KPut Options Held
809K-
Vanguard Group Inc Valley Forge, PA6.11MShares$847 Million0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$705 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA4.29MShares$594 Million0.13% of portfolio
-
Ubs Group Ag2.39MShares$332 Million0.07% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.95MShares$270 Million0.75% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $7.05B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...